Patients with D2T-PsA can be stratified into inflammatory and noninflammatory phenotypes, with the former linked to higher sonographic activity.

In adults with early PsA, golimumab with methotrexate and corticosteroids shows no significant difference in improving PsA ...

A subset of patients with PsA achieved rapid and sustained remission following treatment with b/tsDMARDs and were classified as a super-responder phenotype.

Patients with PsA have a higher prevalence of MetS compared with members of the general population and individuals with other inflammatory arthropathies.